Alterity Therapeutics reports positive results from MSA drug trial Jul 28, 2025 07:26AM
Alterity Therapeutics (ATHE) Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy Jul 17, 2024 07:35AM